Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development

FDA announces withdrawal of the proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products

Original source:

Also Read:   La FDA les recomienda a los consumidores que eviten las cebollas rojas de un proveedor en California; la investigación continúa para encontrar la fuente